key: cord-0861473-hsh9a0nu authors: Olak, André S.; Susuki, Aline M.; Kanashiro, Milena; Paoliello, Monica M.B.; Aschner, Michael; Urbano, Mariana R. title: Risk factors associated with COVID-19-induced death in patients hospitalized in intensive care units (ICUs) in a city in Southern Brazil date: 2021-08-05 journal: Toxicol Rep DOI: 10.1016/j.toxrep.2021.07.020 sha: d9d4b07d8551c562ee74a62cefc883a82444b123 doc_id: 861473 cord_uid: hsh9a0nu OBJECTIVES: The aim of this research was to address risk factors associated with death after hospitalization in intensive care units (ICUs) in 728 COVID-19 patients in Londrina, the second most populated city in the State of Paraná – Brazil, between March and December 2020. METHODS: Statistical analysis, including multiple logistic regression was performed to identify risk factors associated with death in these patients. RESULTS: The results showed that age (60 years or more, O.R. = 3.13, C.I. 95% [2.02; 4.84]), days in the ICU (11 days or more, O.R. = 1.76, C.I. 95% [1.16; 2.66]), neurological diseases (O.R. = 2.15, C.I. 95% [1.07; 4.31]), pneumopathy (O.R = 2.19, C.I. 95% [1.01; 4.82]), diabetes (O.R. = 1.55, C.I. 95% [1.03; 2.32]), and kidney disease (O.R. = 2.27, C.I. 95% [1.18; 4.70]) were associated with increased risk for death from COVID-19. CONCLUSION: Knowing the risk factors associated with death after ICUs hospitalization is useful for identifying the most vulnerable groups, as well as for defining vaccination priorities, considering its scarcity in many parts of the world, mainly in underdeveloped countries, including Brazil. The COVID-19 started in Wuhan, Hubei, China, in December 2019 [1] , spread rapidly to other locations around the world, and was classified as global pandemic by the World Health Organization (WHO) as of March 11, 2020 [2] . The rapid spread of COVID-19 is associated with the high transmissibility of the virus SARS-CoV2 [3] , and the person-to-person transmission that occurs from asymptomatic COVID-19 subjects to others [4] , increasing transmission. Most people infected with COVID-19 are asymptomatic or with few symptoms such as anosmia, hyposmia, dysgeusia, shortness of breath, fever and fatigue [5, 6, 7] . More severe symptoms of COVID-19 include mild to severe acute respiratory distress, J o u r n a l P r e -p r o o f gastrointestinal, liver, cardiac, renal and pancreatic dysfunction, as well as central and peripheral neurological manifestations [8, 9] . Brazil, with a population approximating 212,000,000 inhabitants had the first COVID-19 case confirmed on February 25, 2020, representing the first reported case of COVID-19 in South America [10] . On March, 2021, Brazil was designated as the epicenter of COVID-19 with more than 2,000 deaths daily, more than 12 million cases overall, and over 300,000 deaths, globally ranking second in both cases and deaths in absolute numbers, second only to the United States [11]. The Brazilian Unified Health System ("Sistema Unico de Saude" -SUS) provides universal and free-of-charge access to a comprehensive set of healthcare services for the population [12] . According to Correa-Galendi et al. [13] , about 70% of the population is exclusively insured with SUS and private insurance companies offer supplementary coverage. The city of Londrina, located in northern State of Parana (one of the 26 Brazilian States, located in Southern Brazil), has an estimated population of 575,377 inhabitants according to IBGE [14] , and it is the second most populous city in Parana. The first COVID-19 case in Londrina was confirmed on March 18, 2020, and immediately thereafter, the City Hall and the Paraná State Government established restrictive measures to contain the spread of the virus [15] . COVID-19 is novel disease, and its characteristics are recognized as the disease progresses. Indeed, issues related to mortality and risk factors are fluid, being updated in the course of the pandemic [16] . Even among newly reported studies, most COVID-19 prediction models still lack validation [17] . Taken together, and considering that further studies are needed to better understand the disease, the aim of this research was to J o u r n a l P r e -p r o o f describe the comorbidity profile of COVID-19 patients hospitalized in intensive care units (ICUs) in Londrina, and risk factors associated to death after hospitalization in ICUs. The Parana Health Administration is divided in 22 "Health-Regions" (HR). The city of Londrina is the headquarters of the second most authoritative HR in the State (shown as 17th HR in Figure 1 ). To identify risk factors associated with death from COVID-19 after hospitalization in the ICUs, we performed univariate and multiple logistic regression, considering death (yes/no) as a response variable, and age, comorbidities and days in ICU as explanatory variables. All analyses were conducted with software R [18] . From the 728 COVID-19 patients that were admitted to the ICU between March and December, 2020, 363 recovered from the disease and 365 died. Most patients in both groups were male, i.e. 56.5% in the recovered group and 61.6% in the group of patients that died. In the latter group, the majority (82.7%) were elderly (60-years or older), while in the recovered group 49.6% were in this age range (Table 1) . For the analysis of associated factors related to death by COVID-19 after ICU hospitalization, the following variables were considered: gender, age, days in ICU, neurological disease, pneumopathy, diabetes, kidney disease, obesity and heart disease. Hematological disease, Down´s syndrome, liver disease, asthma and immune depressive variables were also available, but were not included in the analysis, given that greater than 95% of COVID-19 patients in both groups did not clinically present with these comorbidities. The results of the univariate and multiple logistic regression with the respective unadjusted O.R. and adjusted O.R. are presented in Table 1 . Our results corroborated the previously described association between risk of death from COVID-19 and age greater than 60 [16, 19, 20, 21, 22, 23] or 65 years [17, 24] . Kidney disease was also previously associated with deaths and/or higher risk of severe cases [17, 21] . A past history of chronic kidney disease can be one possible explanation, considering that it may lead to a proinflammatory state with functional defects in innate and adaptive immune cell populations and consequently may result in a higher risk for upper respiratory tract infection and pneumonia [22] . Additionally, patients with COVID-19 that develop acute kidney injury with an abrupt loss of kidney function, may also be at increased risk of mortality and morbidity [22] . We observed lack of evidence for an association between gender and death after ICU hospitalization, unlike other studies where being a male was a predictor for hospital death [23, 24, 25] . Moreover, fewer than 10% of the population in Brazil and particularly in Londrina have been exposed to the virus until the end of December 2020, and therefore, the results may vary over time as additional cases are identified. As long as the population is not immunized against the virus, it is hard to predict when the COVID-19 pandemic will end, especially considering the rising number of novel viral variants. Therefore, greater knowledge of risk factors associated with death upon ICU admission of COVID-19 patients is essential, not only for overcoming the disease, but also for future challenges, including group prioritization for immunization and preventive campaigns given the shortage of vaccines and the lack of global vaccine strategy [26] . This research addressed risk factors associated to death from COVID- 19 J o u r n a l P r e -p r o o f The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Clinical features of patients infected with 2019 novel coronavirus in Wuhan WHO Declares COVID-19 a Pandemic High transmissibility of COVID-19 near symptom onset COVID-19 transmission through asymptomatic carriers is a challenge to containment, Influenza and Other respiratory viruses Loss of smell and taste in 2013 European patients with mild to moderate COVID-19 Anosmia and ageusia: common findings in COVID-19 patients Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The Lancet COVID-19 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak (Review) SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19 COVID-19 in Latin America: The implications of the first confirmed case in Brazil Brazilian hospitals' performance: an assessment of the unified health system (SUS), Health Care Management Science Economic Modelling of Screenand-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer Evolution of COVID-19 in Londrina (State of Paraná -Brazil) between Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with COVID-19 Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients R: A language and environment for statistical computing, R Foundation for Statistical Computing Characteristic of 523 COVID-19 in Henan Province and a Death Prediction Model Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients Kidney disease is associated with in-hospital death of patients with COVID-19 Development and validation of the patient history COVID-19 (PH-Covid19) scoring system: a multivariable prediction model of death in Mexican patients with COVID-19 Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies COVID-19 inhospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany Coronavirus: Lack of global vaccine strategy has 'imense costs We acknowledge CAPES and Fundação Araucária for the financial support